Laval, QC, Canada
In 2009, Vertex established its Canadian research and development site in Laval, Quebec, Canada through the acquisition of ViroChem Pharma. Today, Vertex’s Laval scientists are focused on developing new approaches to the treatment of Crohn’s disease, ulcerative colitis and other diseases.
Vertex Pharmaceuticals (Canada) Incorporated
Laval (Quebec) H7V 4A7 Canada